Rotavirus vaccine

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

3 competitors in Meningococcal Disease

#DrugCompanyPhaseTrials

1

Paracetamol

GSK

Phase 2

12

Pneumococcal 13-Valent Conjugate Vaccine

Sanofi

Phase 2

13

Dtap-Hepb-IPV-Hib Vaccine

Sanofi

Phase 2

14

Rotavirus vaccine

Sanofi

Phase 2

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Vaccine6 trials

Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 4·NCT00737503·4,550 enrolled

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

Completed·GSK·Phase 2·NCT00346892·450 enrolled

Baby Vaccine Study (Sched3)

Completed·UUniversity of Oxford·Phase 2·NCT02482636·189 enrolled

Show 3 more trials

A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy

Unknown status·FFederico II University··NCT05212935·2,000 enrolled

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Recruiting·Sanofi·Phase 3·NCT07348692·896 enrolled

A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Completed·Sanofi·Phase 2·NCT01049035·580 enrolled

Rotavirus Vaccine4 trials

Rotavirus Vaccine Produced by Butantan Institute

Completed·BButantan Institute·Phase 1·NCT00981669·80 enrolled

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

Unknown status·SSichuan Center for Disease Control and Prevention·Phase 4·NCT02153866·2,800 enrolled

Immunogenicity of Rotavirus Vaccine

Completed·PPATH·Phase 4·NCT01199874·1,140 enrolled

Show 1 more trial

Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model

Completed·CCentre for Infectious Disease Research in Zambia·N/A·NCT04123119·22 enrolled

Immunogenicity3 trials

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)

Completed·MMCM Vaccines B.V.·Phase 3·NCT01480258·1,315 enrolled

Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates

Completed·PPT Bio Farma·Phase 1·NCT03462108·100 enrolled

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico

Completed·Sanofi·Phase 3·NCT03630705·525 enrolled

Pediatric2 trials

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Completed·Sanofi·Phase 3·NCT03673462·2,797 enrolled

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Completed·Sanofi·Phase 3·NCT05794230·1,528 enrolled

Vaccines2 trials

Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines

Completed·PPATH·Phase 4·NCT01616693·620 enrolled

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Completed·GSK·Phase 3·NCT00140686·3,994 enrolled

3 more indications

Gastroenteritis2 trials

Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger

Completed·EEpicentre·Phase 3·NCT02145000·6,586 enrolled

Gastroenteritis From Rotavirus Infection in Brazilian Children Less Than 5 Years of Age (Study V260-031).

Terminated·Merck & Co.··NCT01195844·230 enrolled

Meningococcal Disease1 trial

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Active, not recruiting·Sanofi·Phase 1/2·NCT06647407·750 enrolled

Respiratory Syncytial Virus1 trial

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Terminated·Sanofi·Phase 3·NCT06397768·2,226 enrolled

Details

Drug Info

Related News